The DOI matches its Crossref record; 55 of the 57 references it cites were found in a registry or an index.
The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review
Abstract
OBJECTIVES: Patients with RA have an increased prevalence of cardiovascular disease (CVD). This is due to traditional risk factors and the effects of chronic inflammation. MTX is the first-choice DMARD in RA. We performed a systematic literature review to determine whether MTX affects the risk of CVD in patients with RA. METHODS: We searched Medline, Embase, Cochrane database, database of abstracts of reviews of effects, health technology assessment and Science Citation Index from 1980 to 2008. Conference proceedings (British Society of Rheumatology, ACR and EULAR) were searched from 2005 to 2008. Papers were included if they assessed the relationship between MTX use and CVD in patients with RA. Two reviewers independently assessed each title and abstract for relevance and quality. RESULTS: A total of 2420 abstracts were identified, of which 18 fulfilled the inclusion criteria. Two studies assessed the relationship between MTX use and CVD mortality, one demonstrated a significant reduction in CVD mortality and the second a trend towards reduction. Five studies considered all-cause CVD morbidity. Four demonstrated a significant reduction in CVD morbidity and the fifth a trend towards reduction. MTX use in the year prior to the development of RA decreased the risk of CVD for 3-4 years. Four studies considered myocardial infarction, one demonstrated a decreased risk and three a trend towards decreased risk with MTX use. CONCLUSION: The current evidence suggests that MTX use is associated with a reduced risk of CVD events in patients with RA. This suggests that reducing the inflammation in RA using MTX not only improves disease-specific outcomes but may also reduce collateral damage such as atherosclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Non-randomized observational studies report reductions in rates of vascular events and cardiovascular death among both rheumatoid arthritis and psoriasis patients being treated with weekly methotrexate in doses ranging from 10 to 20 mg.187,188”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [187]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J. J., Gotto, A. M., Kastelein, J. J. P., Köenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000344393.60303.0a · Cited by 3,641
Sanderson, S., Tatt, I. D., & Higgins, J. P. (2007) · International Journal of Epidemiology · doi:10.1093/ije/dym018 · Cited by 1,531
Being big or growing fast: systematic review of size and growth in infancy and later obesity
Baird, J., Fisher, D., Lucas, P., Kleijnen, J., Roberts, H., & Law, C. (2005) · BMJ · doi:10.1136/bmj.38586.411273.e0 · Cited by 1,185
Self-citationMethotrexate and mortality in patients with rheumatoid arthritis: a prospective study
Choi, H. K., Hernán, M. Á., Seeger, J. D., Robins, J. M., & Wolfe, F. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08213-2 · Cited by 1,133
Cardiovascular Risk and Inhibition of Cyclooxygenase
McGettigan, P., & Henry, D. A. (2006) · JAMA · doi:10.1001/jama.296.13.jrv60011 · Cited by 1,106
Cardiovascular death in rheumatoid arthritis: A population‐based study
Kremers, H. M., Nicola, P., Crowson, C. S., Ballman, K. V., & Gabriel, S. E. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20878 · Cited by 941
Explaining How “High-Grade” Systemic Inflammation Accelerates Vascular Risk in Rheumatoid Arthritis
Sattar, N. A., McCarey, D. W., Capell, H. A., & McInnes, I. B. (2003) · Circulation · doi:10.1161/01.cir.0000099844.31524.05 · Cited by 932
Efficacy of Low-Dose Methotrexate in Rheumatoid Arthritis
Weinblatt, M. E., Coblyn, J. S., Fox, D. A., Fraser, P. A., Holdsworth, D. E., Glass, D. N., & Trentham, D. E. (1985) · New England Journal of Medicine · doi:10.1056/nejm198503283121303 · Cited by 872
Ridker, P. M., Wilson, P. W. F., & Grundy, S. M. (2004) · Circulation · doi:10.1161/01.cir.0000132467.45278.59 · Cited by 645
Research works printed but not linked: 11
- Symmons, 1998, The Journal of Rheumatology, 25, 1072
- 1985, CLINICAL AND IMMUNOLOGIC EFFECTS IN A RANDOMIZED DOUBLEBLIND STUDY ANN INTERN MED, 103, 489
- 1985, A CONTROLLED CLINICAL TRIAL ARTHRITIS RHEUM, 28, 721
- Thompson, 1984, The Journal of Rheumatology, 11, 760
- 2008, Rheumatology, 47, ii49
- 2006, Annals of the Rheumatic Diseases, 65, 307
- 2008, Arthritis and rheumatism, 56, 688
- 2007, Arthritis and rheumatism, 56, S293
- GOODSON, 2008, The Journal of Rheumatology, 35, 945
- Seriolo, 2008, Clinical and experimental rheumatology, 26, 159
- Morgan, 1998, The Journal of Rheumatology, 25, 441
Cited by
Sorted by citations
Items 101–200 of 357
Sánchez‐Pérez, H., Quevedo-Abeledo, J. C., de Armas‐Rillo, L., Rúa‐Figueroa, Í., Segura, B. T., Armas‐González, E., Machado, J. D., García-Dopico, J. A., Jiménez, A., Rodríguez‐Lozano, C., et al. (2020) · Rheumatology · doi:10.1093/rheumatology/keaa038 · Cited by 49
Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion
van den Oever, I. A., van Sijl, A. M., & Nurmohamed, M. T. (2013) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x13491025 · Cited by 48
Guin, A., Adhikari, M. C., Chakraborty, S., Sinhamahapatra, P., & Ghosh, A. (2013) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2012.12.027 · Cited by 46
Chronic kidney disease, inflammation, and cardiovascular disease risk in rheumatoid arthritis
Kochi, M., Kohagura, K., Shiohira, Y., Iseki, K., & Ohya, Y. (2017) · Journal of Cardiology · doi:10.1016/j.jjcc.2017.08.008 · Cited by 46
Methotrexate, Cyclosporine A, and Biologics Protect against Atherosclerosis in Rheumatoid Arthritis
Kisiel, B. M., Kruszewski, R., Juszkiewicz, A., Raczkiewicz, A., Bachta, A., Tłustochowicz, M., Staniszewska-Varga, J., Klos, K., Duda, K., Bogusławska-Walecka, R., et al. (2015) · Journal of Immunology Research · doi:10.1155/2015/759610 · Cited by 45
Burggraaf, B., der Stoep, D. F. V. B.-V., de Vries, M. A., Klop, B., Liem, A. H., van de Geijn, G. M., van der Meulen, N., Birnie, E., van der Zwan, E. M., van Zeben, J., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-214075 · Cited by 45
Bikomeye, J. C., Beyer, A., Kwarteng, J. L., & Beyer, K. M. M. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19042426 · Cited by 44
Lipid Paradox in Rheumatoid Arthritis: Changes With Rheumatoid Arthritis Therapies
Amezaga, M., & Suarez-Almazor, M. E. (2012) · Current Rheumatology Reports · doi:10.1007/s11926-012-0269-z · Cited by 44
Focused Cardiovascular Care for Women
Garcia, M. C., Miller, V. M., Gulati, M., Hayes, S. N., Manson, J. E., WENGER, N. K., Merz, C. N. B., Mankad, R., Pollak, A. W., Mieres, J. H., et al. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.11.001 · Cited by 48
Ridker, P. M. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12862 · Cited by 43
Kingsbury, S. R., Tharmanathan, P., Arden, N., Batley, M., Birrell, F. N., Cocks, K., Doherty, M., Edwards, C. J., Garrood, T., Grainger, A. J., et al. (2015) · Trials · doi:10.1186/s13063-015-0602-8 · Cited by 43
Self-citationStigliano, C., Ramirez, M., Singh, J. V., Aryal, S., Key, J., Blanco, E., & Decuzzi, P. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201601286 · Cited by 42
Cardiovascular effects of methotrexate in immune‑mediated inflammatory diseases (Review)
Bălănescu, A., Bojinca, V. C., Bojincă, M., Donisan, T., & Balanescu, S. M. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6992 · Cited by 42
Ischemic heart disease in systemic inflammatory diseases. An appraisal
Gargiulo, P., Marsico, F., Parente, A., Paolillo, S., Cecere, M., Casaretti, L., Pellegrino, A. M., Formisano, T., Fabiani, I., Soricelli, A., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.11.048 · Cited by 41
Hodkinson, B., van Duuren, E., Pettipher, C. A., & Kalla, A. A. (2013) · South African Medical Journal · doi:10.7196/samj.7047 · Cited by 43
Effects of Methotrexate on Carotid Intima-media Thickness in Patients with Rheumatoid Arthritis
Kim, H.-J., Kim, M. J., Lee, C. K., & Hong, Y. (2015) · Journal of Korean Medical Science · doi:10.3346/jkms.2015.30.11.1589 · Cited by 40
Galectins in the Pathogenesis of Rheumatoid Arthritis
Koehn, Y. Y. C. D. (2013) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000164 · Cited by 40
Widdifield, J., Abrahamowicz, M., Paterson, J. M., Huang, A., Thorne, C., Pope, J. E., Kuriya, B., Beauchamp, M., & Bernatsky, S. (2018) · The Journal of Rheumatology · doi:10.3899/jrheum.180427 · Cited by 39
The Therapeutic Potential of Anti-Inflammatory Exerkines in the Treatment of Atherosclerosis
Yu, M., Tsai, S., & Kuo, Y. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061260 · Cited by 39
Moens, S. J. B., van der Valk, F. M., Strang, A. C., Kroon, J., Smits, L. P., Kneepkens, E. L., Verberne, H. J., van Buul, J. D., Nurmohamed, M. T., & Stroes, E. S. G. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-1008-z · Cited by 38
Sudden cardiac death in patients with rheumatoid arthritis
Masoud, S., Lim, P. B., Kitas, G. D., & Panoulas, V. F. (2017) · World Journal of Cardiology · doi:10.4330/wjc.v9.i7.562 · Cited by 38
Pereira, I. A., da Mota, L. M. H., Cruz, B. A., Brenol, C. V., Fronza, L. S. R., Bértolo, M. B., Freitas, M. V. C., da Silva, N. A., Louzada‐Júnior, P., Giorgi, R. D. N., et al. (2012) · PubMed · Cited by 38
Exploring Cardiovascular Risk Factors and Atherosclerosis in Rheumatoid Arthritis
Drosos, A. A., Venetsanopoulou, A. I., Pelechas, E., & Voulgari, P. V. (2024) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2024.07.016 · Cited by 37
Kuller, L. H., Mackey, R. H., Walitt, B. T., Deane, K. D., Holers, V. M., Robinson, W. H., Sokolove, J. B., Chang, Y., Liu, S., Parks, C. G., et al. (2013) · Arthritis & Rheumatology · doi:10.1002/art.38268 · Cited by 37
MethotrexaTE THerapy in ST-Segment Elevation MYocardial InfarctionS
Moreira, D. M., Lueneberg, M. E., da Silva, R. L., Fattah, T., & Gottschall, C. A. M. (2017) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248417699884 · Cited by 37
Qiu, C., Zhao, X., She, L., Shi, Z., Deng, Z., Tan, L., Tu, X., Jiang, S., & Tang, B. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-0994-7 · Cited by 37
New evidence on the role of inflammation in CVD risk
Lorenzatti, A. J., & Servato, L. (2019) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000625 · Cited by 39
Lan, C.-C. E., Ko, Y., Yu, H., Wu, C., Li, W.-C., Lu, Y., Chen, Y.-C., Chin, Y.-Y., Yang, Y., & Chen, G. (2012) · Acta Dermato Venereologica · doi:10.2340/00015555-1283 · Cited by 36
Recent advances in therapeutic targeting of inflammation in atherosclerosis
Hedin, U., & Matic, L. P. (2018) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2018.10.051 · Cited by 37
Skeletal muscle disease in rheumatoid arthritis: the center of cardiometabolic comorbidities?
Andonian, B. J., & Huffman, K. M. (2020) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000697 · Cited by 35
Key Chemokine Pathways in Atherosclerosis and Their Therapeutic Potential
Márquez, A. B., van der Vorst, E. P. C., & Maas, S. L. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10173825 · Cited by 37
Chan, Y., & Ramji, D. P. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-1924-7_1 · Cited by 41
Increased Prevalence of Metabolic Syndrome in Patients with Psoriatic Arthritis
Pehlevan, S., Yetkin, D. Ö., Bahadır, C., Göktay, F., Pehlevan, Y., Kayataş, K., & İnce, N. (2013) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2013.0039 · Cited by 35
Edwards, C. J., Campbell, J., van Staa, T. P., & Arden, N. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-001603 · Cited by 35
Self-citationKastbom, A., Ärlestig, L., & Rantapää‐Dahlqvist, S. (2015) · The Journal of Rheumatology · doi:10.3899/jrheum.141529 · Cited by 35
Tam, H., Yeo, K., Leong, P., Chen, C.-H., Li, Y., Ma, C.-M., Wang, Y., Chiou, J., & Wei, J. C. (2016) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.12986 · Cited by 36
Moreira, D. M., Lueneberg, M. E., da Silva, R. L., Fattah, T., & Gottschall, C. A. M. (2013) · Cardiology · doi:10.1159/000351972 · Cited by 34
Chen, Y., Rivera, J., Fitzgerald, M., Hausding, C., Ying, Y.-L., Wang, X., Todorova, K. O., Hayrabedyan, S., Barnea, E. R., & Peter, K. (2016) · Thrombosis and Haemostasis · doi:10.1160/th15-08-0640 · Cited by 36
Endothelial Cx40 limits myocardial ischaemia/reperfusion injury in mice
Morel, S., Braunersreuther, V., Chanson, M., Bouïs, D., Rochemont, V., Foglia, B. F., Pelli, G., Sutter, E., Pinsky, D. J., Mach, F., et al. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu063 · Cited by 34
Cardiovascular Disease in Rheumatoid Arthritis
Sen, D., González-Mayda, M., & Brasington, R. (2013) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2013.10.005 · Cited by 32
Raychaudhuri, S. P. (2012) · The Journal of Rheumatology · doi:10.3899/jrheum.111244 · Cited by 32
Huang, L., Chang, Y.-H., & Yang, Y. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00715-6 · Cited by 32
Filippatos, T. D., Derdemezis, C. S., Voulgari, P. V., Tsimihodimos, V., Elisaf, M., Tselepis, A. D., & Drosos, A. A. (2013) · Scandinavian Journal of Rheumatology · doi:10.3109/03009742.2012.745013 · Cited by 32
Progression of noncalcified and calcified coronary plaque by CT angiography in SLE
Khan, A., Arbab‐Zadeh, A., Kiani, A. N., Magder, L. S., & Petri, M. (2016) · Rheumatology International · doi:10.1007/s00296-016-3615-z · Cited by 31
Katsuyama, T., Sada, K., Yan, M., Zeggar, S., Hiramatsu, S., Miyawaki, Y., Ohashi, K., Morishita, M., Watanabe, H., Katsuyama, E., et al. (2016) · Modern Rheumatology · doi:10.1080/14397595.2016.1259714 · Cited by 31
Vassilopoulos, D., Gravos, A., Vlachopoulos, C. V., Kandili, A., Ioakeimidis, N., Pectasides, D. G., & Stefanadis, C. (2014) · Clinical Rheumatology · doi:10.1007/s10067-014-2718-8 · Cited by 30
Xie, F., Chen, L., Yun, H., Levitan, E. B., & Curtis, J. R. (2020) · The Journal of Rheumatology · doi:10.3899/jrheum.191326 · Cited by 30
Anti-inflammatory Strategies in Atherosclerosis
Bugger, H., & Zirlik, A. (2021) · Hämostaseologie · doi:10.1055/a-1661-0020 · Cited by 32
Increased cardiovascular risk in patients with rheumatoid arthritis: an overview
Puttevils, D., Vusser, P. D., Geusens, P., & Dens, J. (2014) · Acta cardiologica. Supplementum · doi:10.1080/ac.69.2.3017291 · Cited by 31
Scott, D., Claydon, P., & Ellis, C. J. (2014) · Scandinavian Journal of Rheumatology · doi:10.3109/03009742.2014.910312 · Cited by 29
Lorenzatti, A. J., & Servato, L. (2018) · European Cardiology Review · doi:10.15420/ecr.2018.11.1 · Cited by 28
A Perspective on Targeting Inflammation and Cytokine Actions in Atherosclerosis
Chan, Y., & Ramji, D. P. (2020) · Future Medicinal Chemistry · doi:10.4155/fmc-2019-0301 · Cited by 29
Rheumatoid arthritis and the era of biologic therapy
Malaviya, A. P., & Östör, A. J. K. (2012) · Inflammopharmacology · doi:10.1007/s10787-012-0123-y · Cited by 27
Tackling inflammation in atherosclerosis: Are we there yet and what lies beyond?
Bhattacharya, P., Kanagasooriyan, R., & Subramanian, M. (2022) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2022.102283 · Cited by 31
Vyletelová, V., Nováková, M., & Pašková, Ľ. (2022) · Pharmaceuticals · doi:10.3390/ph15101278 · Cited by 30
Chronic rheumatologic disorders and cardiovascular disease risk in women
Mehta, P. K., Levit, R. D., Wood, M. J., Aggarwal, N. R., O’Donoghue, M. L., Lim, S. S., Lindley, K., Gaignard, S. M., Quesada, O., Vatsa, N., et al. (2023) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2023.100267 · Cited by 29
Davis, L. A., Cannon, G. W., Pointer, L., Haverhals, L. M., Wolff, R. K., Mikuls, T. R., Reimold, A. M., Kerr, G. S., Richards, J. S., Johnson, D. S., et al. (2013) · The Journal of Rheumatology · doi:10.3899/jrheum.121012 · Cited by 27
Giudice, E. D., Dilillo, A., Tromba, L., Torre, G. L., Blasi, S., Conti, F., Viola, F., Cucchiara, S., & Duse, M. (2017) · Clinical Rheumatology · doi:10.1007/s10067-017-3705-7 · Cited by 28
Mavrogeni, S. I., Sfikakis, P. P., Dimitroulas, T., Koutsogeorgopoulou, L. A., Katsifis, G. E., Markousis‐Mavrogenis, G., Kolovou, G. D., & Kitas, G. D. (2018) · Rheumatology International · doi:10.1007/s00296-018-4004-6 · Cited by 27
Russo, G. T., Minutoli, L., Bitto, A., Altavilla, D., Alessi, E., Giandalia, A., Romeo, E. L., Stagno, M. F., Squadrito, F., Cucinotta, D., et al. (2012) · Journal of Nutrition and Metabolism · doi:10.1155/2012/132056 · Cited by 26
Anti-inflammatory drugs as promising cardiovascular treatments
Huet, F., Akodad, M., Fauconnier, J., Lacampagne, A., & Roubille, F. (2016) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2017.1273771 · Cited by 26
Cardiovascular Safety of Biologics and JAK Inhibitors in Patients with Rheumatoid Arthritis
Kang, E. H., Liao, K. P., & Kim, S. C. (2018) · Current Rheumatology Reports · doi:10.1007/s11926-018-0752-2 · Cited by 25
Atherosclerotic Vascular Disease in the Autoimmune Rheumatologic Patient
Mankad, R. (2015) · Current Atherosclerosis Reports · doi:10.1007/s11883-015-0497-6 · Cited by 24
Psoriasis, inflammation, and vascular risk: a problem more than skin deep?
Ridker, P. M. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq042 · Cited by 25
Kraakman, M. J., Dragoljevic, D., Kammoun, H. L., & Murphy, A. J. (2016) · Clinical & Translational Immunology · doi:10.1038/cti.2016.31 · Cited by 25
Cardiovascular risk in patients with spondyloarthritis and association with anti-TNF drugs
Chan, S. C. W., Teo, K. C., Li, P. H., Lau, K. K., Lau, C. S., & Chung, H. Y. (2021) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x211032444 · Cited by 24
Chen, Y., Liu, S., Lai, K., Tang, K., Lin, C., Chen, Y., Tseng, C., Chang, Y., Gotcher, D. F., Chiou, C.-C., et al. (2021) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x211030809 · Cited by 23
Wang, Y., Chen, T., Yang, C., Li, Q., Ma, M., Xu, H., Shi, Q., Wang, Y., Wang, Y., & Liang, Q. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.871481 · Cited by 23
Nasonov, E. L., Karateev, D. E., & Chichasova, N. V. (2014) · Rheumatology Science and Practice · doi:10.14412/1995-4484-2014-8-26 · Cited by 23
Schmieder, A., Poppe, M., Hametner, C., Meyer-Schraml, H., Schaarschmidt, M., Findeisen, P., Benoit, S., Bauer, B., Schmid, S., Goebeler, M., et al. (2015) · Archives of Dermatological Research · doi:10.1007/s00403-015-1541-7 · Cited by 23
Cardiovascular risk and inflammatory rheumatic diseases
Alhusain, A., & Bruce, I. N. (2013) · Clinical Medicine · doi:10.7861/clinmedicine.13-4-395 · Cited by 23
Tufaro, V., Serruys, P. W. J. C., Räber, L., Bennett, M. R., Torii, R., Gu, S. Z., Onuma, Y., Mathur, A., Baumbach, A., & Bourantas, C. V. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac051 · Cited by 22
Bartoloni, E., Alunno, A., Bistoni, O., & Gerli, R. (2011) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-010-8251-x · Cited by 22
Mittal, R., Jhaveri, V. M., McMurry, H. S., Kay, S.-I. S., Sutherland, K. J., Lin, N., Mittal, J., & Jayant, R. D. (2018) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2018.1436555 · Cited by 22
Lorenzatti, A. J., & Retzlaff, B. M. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.07.061 · Cited by 23
Anti-inflammatory and Immunomodulatory Therapies in Atherosclerosis
Deroissart, J., Porsch, F., Köller, T., & Binder, C. J. (2021) · Handbook of experimental pharmacology · doi:10.1007/164_2021_505 · Cited by 24
Meng, H., Lam, S. H. M., So, H., & Tam, L. (2024) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2024.152416 · Cited by 21
Ristić, G. G., Subota, V., Lepić, T., Stanisavljevic, D. M., Glišić, B., Ristić, A. D., Petronijević, M., & Stefanović, D. Z. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130462 · Cited by 21
Cardiovascular risk factors in inflammatory arthritis
Mirjafari, H., Alhusain, A., & Bruce, I. N. (2011) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283488c50 · Cited by 21
Cardiovascular risk assessment in rheumatoid arthritis – controversies and the new approach
Bonek, K., & Głuszko, P. (2016) · Reumatologia/Rheumatology · doi:10.5114/reum.2016.61214 · Cited by 24
Anti-inflammatory Therapies for Cardiovascular Disease: Signaling Pathways and Mechanisms
Martínez‐Hervás, S., & Navarro, H. G. (2019) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2019.03.007 · Cited by 22
Cho, S., Kim, D., Won, S., Lee, J., Park, B., Jang, E. J., Bae, S., & Sung, Y. (2017) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2017.08.002 · Cited by 20
Paccou, J., Renard, C., Liabeuf, S., Kamel, S., Fardellone, P., Massy, Z. A., Brazier, M., & Mentaverri, R. (2014) · The Journal of Rheumatology · doi:10.3899/jrheum.140239 · Cited by 20
Chronic Inflammation and Atherosclerosis
Nilsson, J. Å., Gonçalves, I., & Edsfeldt, A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801387-8.00016-8 · Cited by 19
Pereira, I. A., da Mota, L. M. H., Cruz, B. A., Brenol, C. V., Fronza, L. S. R., Bértolo, M. B., Freitas, M. V. C., da Silva, N. A., Louzada‐Júnior, P., Giorgi, R. D. N., et al. (2012) · Revista Brasileira de Reumatologia · doi:10.1590/s0482-50042012000400002 · Cited by 19
Arterial wall inflammation in rheumatoid arthritis is reduced by anti-inflammatory treatment
Blanken, A. B., Agca, R., van Sijl, A. M., Voskuyl, A. E., Boellaard, R., Smulders, Y. M., van der Laken, C. J., & Nurmohamed, M. T. (2021) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2021.03.008 · Cited by 19
van Sijl, A. M., van den Hurk, K., Peters, M. J. L., van Halm, V. P., Nijpels, G., Stehouwer, C. D. A., Smulders, Y. M., Voskuyl, A. E., DEKKER, J. M., & Nurmohamed, M. T. (2012) · The Journal of Rheumatology · doi:10.3899/jrheum.120617 · Cited by 19
Erhayiem, B., Pavitt, S. H., Baxter, P. D., Andrews, J., Greenwood, J. P., Buch, M. H., & Plein, S. (2014) · Trials · doi:10.1186/1745-6215-15-436 · Cited by 19
Horton, S. C., Walsh, C. A., & Emery, P. (2011) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2011.10.012 · Cited by 19
Wibetoe, G., Sexton, J., Ikdahl, E., Rollefstad, S., Kitas, G. D., van Riel, P. L. C. M., Gabriel, S. E., Kvien, T. K., Douglas, K., Sandoo, A., et al. (2020) · Arthritis Research & Therapy · doi:10.1186/s13075-020-02178-z · Cited by 18
Sintek, M. A., Sparrow, C. T., Mikuls, T. R., Lindley, K. J., Bach, R. G., Kurz, H. I., Novak, E. L., & Singh, J. (2015) · Heart · doi:10.1136/heartjnl-2015-308634 · Cited by 18
Anti-inflammatory Treatment and Cardiovascular Outcomes: Results of Clinical Trials
Lorenzatti, A. J. (2021) · European Cardiology Review · doi:10.15420/ecr.2020.51 · Cited by 17
Cardiovascular Risk in Psoriasis Patients: Clinical, Functional and Morphological Parameters
de Oliveira, A. N., Simões, M. M., Simões, R., Malachias, M. V. B., & Rezende, B. A. (2019) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20190123 · Cited by 17
Kardiovaskuläre Komorbidität und ihre Risikofaktoren bei rheumatoider Arthritis
Kleinert, S., & Krueger, K. (2011) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-011-0755-0 · Cited by 16
Psoriatic Disease: Clinical Staging
Scarpa, R., Caso, F., Costa, L., Peluso, R., Spano, A., Lubrano, E., Puente, A. D., & Moll, J. M. H. (2015) · Journal of Rheumatology Supplement · doi:10.3899/jrheum.150629 · Cited by 16
Cardiovascular inflammation is reduced with methotrexate in diabetes
Quan, A., Pan, Y., Singh, K. K., Polemidiotis, J., Teoh, H., Leong-Poi, H. M., & Verma, S. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-017-3006-0 · Cited by 16
Cardiovascular Risk Factor and Atherosclerosis in Rheumatoid Arthritis (RA)
Kattamuri, L. P. V., Duggal, S., Aparece, J. P., & Sairam, S. (2025) · Current Cardiology Reports · doi:10.1007/s11886-025-02198-8 · Cited by 18
MicroRNA-126 enhances the sensitivity of osteosarcoma cells to cisplatin and methotrexate
Jiang, L., Ai-yong, H., He, X., & Cheng, T. (2015) · Oncology Letters · doi:10.3892/ol.2015.3790 · Cited by 15
Todoerti, M., Maglione, W., Bernero, E., Bortoluzzi, A., Colaci, M., Galuppi, E., Paolino, S., Talarico, R., Cutolo, M., Ferri, C., et al. (2013) · Reumatismo · doi:10.4081/reumatismo.2013.207 · Cited by 15
Evensen, K., Aulie, H. A., Rønning, O. M., Flatø, B., & Russell, D. (2016) · The Journal of Rheumatology · doi:10.3899/jrheum.150499 · Cited by 15
Metadata
- Authors
- Westlake, S. L., Colebatch, A. N., Baird, J., Kiely, P., Quinn, M., Choy, E., Ostor, A. J. K., & Edwards, C. J.
- Affiliations
- King's College London (GB)
- Venue
- Rheumatology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-11-27
- Volume
- 49
- Issue
- 2
- Pages
- 295-307
- ISSN
- 1462-0324 (ISSN-L)
- 1462-0332
- OpenAlex
- W2100260684
- Cited by
- 357
- References
- 57
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 7 · 2023: 10 · 2022: 15 · 2021: 18 · 2020: 15 · 2019: 26 · 2018: 20 · 2017: 25 · 2016: 32 · 2015: 38 · 2014: 25 · 2013: 33 · 2012: 42
- FWCI
- 3.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Lara D. Veeken (publishedVersion)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Health Sciences › Medicine › Nephrology › Gout, Hyperuricemia, Uric Acid
- Keywords
- methotrexate, rheumatoid arthritis, cardiovascular disease, cardiovascular mortality, cardiovascular morbidity, myocardial infarction, atherosclerosis, disease-modifying antirheumatic drugs, chronic inflammation
- MeSH terms
- Arthritis, Rheumatoid, Cardiovascular Diseases, Humans, Immunosuppressive Agents, Insulin Resistance, Lipids, Methotrexate, Antirheumatic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
